Whether plasma ACE2 concentration per se plays a significant role in pathophysiology and susceptibility in COVID-19 is unclear, but changes in ACE2 concentration and/or activity predict the potential systemic involvement of changes in angiotensin concentrations. The gene discussed is ACE2; the disease is COVID-19.